Intravenous Furosemide in the Management of Transient Tachypnea of Newborn

Objective: To determine the mean length of hospital stay term and late preterm infants with transient tachypnea newborn treated intravenous Furosemide compared to Control Group.
 Study Design: Quasi-experimental study.
 Place Duration Study: Combined Military Hospital, Kharian, from Apr Oct 2016.
 Methodology: All new-borns were included in study. One Group was given IV Furosemide, other taken as control. Two doses administered at 1 mg/kg 12 hours apart. The normal saline 01 ml/kg a placebo 
 Results: It found that duration Study-Group less than Control-Group (49.4±7.4 h vs 76.7±4.5h, p-value <0.001). requirement oxygen Treatment (53.7±6.6h) (84.5±4.2h) (p<0.01). hospitalization 71.4±4.9 hours, 100.0±3.7 (p-value <0.001).
 Conclusion: Using neonates newborns effectively reduces patients. reduced and, subsequently, for patients newborns.